|
|||||
|
|
Medicare program; competitive acquisition of outpatient drugs and biologicals under Part B. Interim final rule with comment period |
|
| Authors: | Centers for Medicare & Medicaid Services , HHS |
| Affiliation: | Centers for Medicare & Medicaid Services (CMS), HHS |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |